Anzemet and White blood cell count abnormal - a phase IV clinical study of FDA data

Summary:

White blood cell count abnormal is reported as a side effect among people who take Anzemet (dolasetron mesylate), especially for people who are female, 40-49 old, also take Decadron, and have Lung cancer - non-small cell.

The phase IV clinical study analyzes which people have White blood cell count abnormal when taking Anzemet. It is created by eHealthMe based on reports of 2,574 people who have side effects when taking Anzemet from the FDA, and is updated regularly.

What is Anzemet?

Anzemet has active ingredients of dolasetron mesylate. eHealthMe is studying from 2,603 Anzemet users. Check the latest studies of Anzemet.

What is White blood cell count abnormal?

White blood cell count abnormal is found to be associated with 555 drugs and 841 conditions by eHealthMe. Check the latest studies of White blood cell count abnormal.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 24, 2026

2,574 people reported to have side effects when taking Anzemet.
Among them, 14 people (0.54%) have White blood cell count abnormal.

Could Anzemet cause White blood cell count abnormal?

Among these 14 people:

What is the gender of people who have White blood cell count abnormal when taking Anzemet? *

female: 78.57 %
male: 21.43 %

What is the age of people who have White blood cell count abnormal when taking Anzemet? *

What are other drugs people take besides Anzemet? *

What are other side effects people have besides White blood cell count abnormal? *

Weight Decreased: 7 people, 50.00%
Nausea And Vomiting: 7 people, 50.00%
Neck Pain: 7 people, 50.00%
Platelet Count Abnormal: 7 people, 50.00%
Nausea (feeling of having an urge to vomit): 7 people, 50.00%
Dyspnea (difficult or laboured breathing): 6 people, 42.86%
Stress And Anxiety: 6 people, 42.86%
Haematocrit: 6 people, 42.86%
Pain: 6 people, 42.86%
Injury: 6 people, 42.86%

What are the existing conditions these people have? *

Nausea (feeling of having an urge to vomit): 5 people, 35.71%
Metastases To Bone (cancer spreads to bone): 5 people, 35.71%
Lung Cancer - Non-Small Cell (lung cancer): 5 people, 35.71%
Deep Venous Thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis): 1 person, 7.14%
Chronic Lymphocytic Leukaemia (cancer in which the bone marrow makes too many lymphocytes (a type of white blood cell)): 1 person, 7.14%
Breast Cancer Stage Iv: 1 person, 7.14%
Breast Cancer: 1 person, 7.14%

* Approximation only. Some reports may have incomplete information.

Do you take Anzemet and have White blood cell count abnormal?

- Check whether White blood cell count abnormal is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Anzemet:

Anzemet (2,603 reports)

Browse all side effects of Anzemet:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with White blood cell count abnormal:

White blood cell count abnormal (555 drugs)

Browse all the conditions that are associated with White blood cell count abnormal:

White blood cell count abnormal (841 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on dolasetron mesylate (the active ingredients of Anzemet) and Anzemet (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.